• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

重新编程 TRAIL/DISC 组件的剪接使肺癌细胞对 TRAIL 介导的细胞凋亡敏感。

Splicing reprogramming of TRAIL/DISC-components sensitizes lung cancer cells to TRAIL-mediated apoptosis.

机构信息

Department of Molecular Genetics, The Ohio State University, Columbus, OH, USA.

Department of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, MD, USA.

出版信息

Cell Death Dis. 2021 Mar 17;12(4):287. doi: 10.1038/s41419-021-03567-1.

DOI:10.1038/s41419-021-03567-1
PMID:33731677
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7969956/
Abstract

Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) selective killing of cancer cells underlines its anticancer potential. However, poor tolerability and resistance underscores the need to identify cancer-selective TRAIL-sensitizing agents. Apigenin, a dietary flavonoid, sensitizes lung cancer cell lines to TRAIL. It remains unknown, however, whether apigenin sensitizes primary lung cancer cells to TRAIL and its underlying mechanisms. Here we show that apigenin reprograms alternative splicing of key TRAIL/death-inducing-signaling-complex (DISC) components: TRAIL Death Receptor 5 (DR5) and cellular-FLICE-inhibitory-protein (c-FLIP) by interacting with the RNA-binding proteins hnRNPA2 and MSI2, resulting in increased DR5 and decreased c-FLIP protein levels, enhancing TRAIL-induced apoptosis of primary lung cancer cells. In addition, apigenin directly bound heat shock protein 70 (Hsp70), promoting TRAIL/DISC assembly and triggering apoptosis. Our findings reveal that apigenin directs alternative splicing and inhibits Hsp70 enhancing TRAIL anticancer activity. These findings underscore impactful synergies between diet and cancer treatments opening new avenues for improved cancer treatments.

摘要

肿瘤坏死因子相关凋亡诱导配体(TRAIL)选择性杀伤癌细胞凸显了其抗癌潜力。然而,较差的耐受性和耐药性突出表明需要确定癌症选择性 TRAIL 敏化剂。芹菜素是一种膳食类黄酮,可使肺癌细胞系对 TRAIL 敏感。然而,尚不清楚芹菜素是否使原发性肺癌细胞对 TRAIL 敏感及其潜在机制。在这里,我们发现芹菜素通过与 RNA 结合蛋白 hnRNPA2 和 MSI2 相互作用,重新编程关键的 TRAIL/死亡诱导信号复合物(DISC)成分的选择性剪接:TRAIL 死亡受体 5(DR5)和细胞-FLICE 抑制蛋白(c-FLIP),导致 DR5 水平增加和 c-FLIP 蛋白水平降低,增强 TRAIL 诱导的原发性肺癌细胞凋亡。此外,芹菜素直接结合热休克蛋白 70(Hsp70),促进 TRAIL/DISC 组装并触发细胞凋亡。我们的研究结果表明,芹菜素指导选择性剪接并抑制 Hsp70 增强 TRAIL 的抗癌活性。这些发现强调了饮食与癌症治疗之间的协同作用具有重要意义,为改善癌症治疗开辟了新途径。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/08ab/7969956/10dfd6a2d44b/41419_2021_3567_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/08ab/7969956/4998849dc9ce/41419_2021_3567_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/08ab/7969956/af954f6dbf6b/41419_2021_3567_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/08ab/7969956/c59effbe09e7/41419_2021_3567_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/08ab/7969956/cf16cbd11f45/41419_2021_3567_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/08ab/7969956/e21fbf43b38a/41419_2021_3567_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/08ab/7969956/10dfd6a2d44b/41419_2021_3567_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/08ab/7969956/4998849dc9ce/41419_2021_3567_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/08ab/7969956/af954f6dbf6b/41419_2021_3567_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/08ab/7969956/c59effbe09e7/41419_2021_3567_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/08ab/7969956/cf16cbd11f45/41419_2021_3567_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/08ab/7969956/e21fbf43b38a/41419_2021_3567_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/08ab/7969956/10dfd6a2d44b/41419_2021_3567_Fig6_HTML.jpg

相似文献

1
Splicing reprogramming of TRAIL/DISC-components sensitizes lung cancer cells to TRAIL-mediated apoptosis.重新编程 TRAIL/DISC 组件的剪接使肺癌细胞对 TRAIL 介导的细胞凋亡敏感。
Cell Death Dis. 2021 Mar 17;12(4):287. doi: 10.1038/s41419-021-03567-1.
2
CCAAT/enhancer binding protein homologous protein-dependent death receptor 5 induction and ubiquitin/proteasome-mediated cellular FLICE-inhibitory protein down-regulation contribute to enhancement of tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by dimethyl-celecoxib in human non small-cell lung cancer cells.CCAAT/增强子结合蛋白同源蛋白依赖性死亡受体5的诱导以及泛素/蛋白酶体介导的细胞FLICE抑制蛋白下调,有助于二甲基塞来昔布增强人非小细胞肺癌细胞中肿瘤坏死因子相关凋亡诱导配体诱导的凋亡。
Mol Pharmacol. 2007 Nov;72(5):1269-79. doi: 10.1124/mol.107.037465. Epub 2007 Aug 7.
3
Apigenin sensitizes prostate cancer cells to Apo2L/TRAIL by targeting adenine nucleotide translocase-2.芹菜素通过靶向腺嘌呤核苷酸转位酶-2使前列腺癌细胞对 Apo2L/TRAIL 敏感。
PLoS One. 2013;8(2):e55922. doi: 10.1371/journal.pone.0055922. Epub 2013 Feb 19.
4
Suppression of HSP70 expression sensitizes NSCLC cell lines to TRAIL-induced apoptosis by upregulating DR4 and DR5 and downregulating c-FLIP-L expressions.抑制 HSP70 表达通过上调 DR4 和 DR5 及下调 c-FLIP-L 的表达使非小细胞肺癌细胞系对 TRAIL 诱导的凋亡敏感。
J Mol Med (Berl). 2013 Feb;91(2):219-35. doi: 10.1007/s00109-012-0947-3. Epub 2012 Sep 5.
5
Lipid rafts and nonrafts mediate tumor necrosis factor related apoptosis-inducing ligand induced apoptotic and nonapoptotic signals in non small cell lung carcinoma cells.脂筏和非脂筏介导肿瘤坏死因子相关凋亡诱导配体在非小细胞肺癌细胞中诱导凋亡和非凋亡信号。
Cancer Res. 2007 Jul 15;67(14):6946-55. doi: 10.1158/0008-5472.CAN-06-3896.
6
Rosiglitazone promotes tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by reactive oxygen species-mediated up-regulation of death receptor 5 and down-regulation of c-FLIP.罗格列酮通过活性氧介导的死亡受体5上调和c-FLIP下调促进肿瘤坏死因子相关凋亡诱导配体诱导的细胞凋亡。
Free Radic Biol Med. 2008 Mar 15;44(6):1055-68. doi: 10.1016/j.freeradbiomed.2007.12.001. Epub 2007 Dec 8.
7
Metformin sensitizes human bladder cancer cells to TRAIL-induced apoptosis through mTOR/S6K1-mediated downregulation of c-FLIP.二甲双胍通过mTOR/S6K1介导的c-FLIP下调使人类膀胱癌细胞对TRAIL诱导的凋亡敏感。
Anticancer Drugs. 2014 Sep;25(8):887-97. doi: 10.1097/CAD.0000000000000116.
8
Inhibition of euchromatin histone-lysine N-methyltransferase 2 sensitizes breast cancer cells to tumor necrosis factor-related apoptosis-inducing ligand through reactive oxygen species-mediated activating transcription factor 4-C/EBP homologous protein-death receptor 5 pathway activation.组蛋白赖氨酸 N-甲基转移酶 2 的抑制作用通过活性氧介导的激活转录因子 4-C/EBP 同源蛋白-死亡受体 5 途径的激活,使乳腺癌细胞对肿瘤坏死因子相关凋亡诱导配体敏感。
Mol Carcinog. 2018 Nov;57(11):1492-1506. doi: 10.1002/mc.22872. Epub 2018 Jul 19.
9
AW00179 potentiates TRAIL-mediated death of human lung cancer H1299 cells through ROS-JNK-c-Jun-mediated up-regulation of DR5 and down-regulation of anti-apoptotic molecules.AW00179 通过 ROS-JNK-c-Jun 介导的上调 DR5 和下调抗凋亡分子来增强 TRAIL 介导的人肺癌 H1299 细胞的死亡。
Amino Acids. 2012 Oct;43(4):1679-87. doi: 10.1007/s00726-012-1249-3. Epub 2012 Feb 22.
10
The dietary flavonoid apigenin sensitizes malignant tumor cells to tumor necrosis factor-related apoptosis-inducing ligand.膳食类黄酮芹菜素可使恶性肿瘤细胞对肿瘤坏死因子相关凋亡诱导配体敏感。
Mol Cancer Ther. 2006 Apr;5(4):945-51. doi: 10.1158/1535-7163.MCT-05-0431.

引用本文的文献

1
Mesenchymal Stem Cells Expressing CES1 and Soluble TRAIL Activate CPT-11 and Induce Apoptosis in Lung Cancer Brain Metastatic Lesions.表达CES1和可溶性TRAIL的间充质干细胞激活CPT-11并诱导肺癌脑转移灶凋亡。
Cancer Res Commun. 2025 Sep 1;5(9):1552-1565. doi: 10.1158/2767-9764.CRC-25-0209.
2
Basic and applied research progress of TRAIL in hematologic malignancies.TRAIL在血液系统恶性肿瘤中的基础与应用研究进展
Blood Sci. 2025 Mar 11;7(2):e00221. doi: 10.1097/BS9.0000000000000221. eCollection 2025 Jun.
3
Apoptosis of Pancreatic Cancer Cells after Co-Treatment with Eugenol and Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand.

本文引用的文献

1
TRAIL of Hope Meeting Resistance in Cancer.希望之路在癌症治疗中遭遇阻力。
Trends Cancer. 2020 Dec;6(12):989-1001. doi: 10.1016/j.trecan.2020.06.006. Epub 2020 Jul 24.
2
Cancer statistics, 2020.癌症统计数据,2020 年。
CA Cancer J Clin. 2020 Jan;70(1):7-30. doi: 10.3322/caac.21590. Epub 2020 Jan 8.
3
Prevention and Early Detection for NSCLC: Advances in Thoracic Oncology 2018.非小细胞肺癌的预防和早期检测:2018 年胸部肿瘤学进展。
丁香酚与肿瘤坏死因子相关凋亡诱导配体联合处理后胰腺癌细胞的凋亡
Cancers (Basel). 2024 Sep 5;16(17):3092. doi: 10.3390/cancers16173092.
4
Signaling controversy and future therapeutical perspectives of targeting sphingolipid network in cancer immune editing and resistance to tumor necrosis factor-α immunotherapy.癌症免疫编辑及对肿瘤坏死因子-α免疫疗法耐药中靶向鞘脂网络的信号争议与未来治疗前景
Cell Commun Signal. 2024 May 2;22(1):251. doi: 10.1186/s12964-024-01626-6.
5
Machine learning reveals diverse cell death patterns in lung adenocarcinoma prognosis and therapy.机器学习揭示了肺腺癌预后和治疗中的多种细胞死亡模式。
NPJ Precis Oncol. 2024 Feb 26;8(1):49. doi: 10.1038/s41698-024-00538-5.
6
TRAIL predisposes non-small cell lung cancer to ferroptosis by regulating ASK-1/JNK1 pathway.肿瘤坏死因子相关凋亡诱导配体通过调节凋亡信号调节激酶1/应激活化蛋白激酶1通路使非小细胞肺癌易发生铁死亡。
Discov Oncol. 2024 Feb 21;15(1):45. doi: 10.1007/s12672-024-00890-9.
7
Heparan sulfate promotes TRAIL-induced tumor cell apoptosis.肝素硫酸盐促进 TRAIL 诱导的肿瘤细胞凋亡。
Elife. 2024 Jan 24;12:RP90192. doi: 10.7554/eLife.90192.
8
Transcriptome reprogramming through alternative splicing triggered by apigenin drives cell death in triple-negative breast cancer.通过芹菜素触发的选择性剪接进行转录组重编程可导致三阴性乳腺癌细胞死亡。
Cell Death Dis. 2023 Dec 13;14(12):824. doi: 10.1038/s41419-023-06342-6.
9
TRAIL-Sensitizing Effects of Flavonoids in Cancer.黄酮类化合物对癌症的 TRAIL 增敏作用。
Int J Mol Sci. 2023 Nov 22;24(23):16596. doi: 10.3390/ijms242316596.
10
Heparan sulfate promotes TRAIL-induced tumor cell apoptosis.硫酸乙酰肝素促进肿瘤坏死因子相关凋亡诱导配体(TRAIL)诱导的肿瘤细胞凋亡。
bioRxiv. 2023 Nov 1:2023.07.26.550758. doi: 10.1101/2023.07.26.550758.
J Thorac Oncol. 2019 Sep;14(9):1513-1527. doi: 10.1016/j.jtho.2019.06.011. Epub 2019 Jun 19.
4
Function, clinical application, and strategies of Pre-mRNA splicing in cancer.mRNA 前体剪接在癌症中的功能、临床应用及策略。
Cell Death Differ. 2019 Jul;26(7):1181-1194. doi: 10.1038/s41418-018-0231-3. Epub 2018 Nov 21.
5
Cancer statistics, 2018.癌症统计数据,2018 年。
CA Cancer J Clin. 2018 Jan;68(1):7-30. doi: 10.3322/caac.21442. Epub 2018 Jan 4.
6
Binding to SMN2 pre-mRNA-protein complex elicits specificity for small molecule splicing modifiers.结合 SMN2 pre-mRNA-蛋白复合物引发小分子剪接调节剂的特异性。
Nat Commun. 2017 Nov 14;8(1):1476. doi: 10.1038/s41467-017-01559-4.
7
RNA-Binding Proteins in Cancer: Old Players and New Actors.癌症中的RNA结合蛋白:老面孔与新角色
Trends Cancer. 2017 Jul;3(7):506-528. doi: 10.1016/j.trecan.2017.05.003. Epub 2017 Jun 20.
8
The TRAIL-Induced Cancer Secretome Promotes a Tumor-Supportive Immune Microenvironment via CCR2.肿瘤坏死因子相关凋亡诱导配体(TRAIL)诱导的癌症分泌组通过CCR2促进肿瘤支持性免疫微环境。
Mol Cell. 2017 Feb 16;65(4):730-742.e5. doi: 10.1016/j.molcel.2017.01.021.
9
Musashi RNA-Binding Proteins as Cancer Drivers and Novel Therapeutic Targets.武藏RNA结合蛋白作为癌症驱动因素和新型治疗靶点
Clin Cancer Res. 2017 May 1;23(9):2143-2153. doi: 10.1158/1078-0432.CCR-16-2728. Epub 2017 Jan 31.
10
Apigenin potentiates TRAIL therapy of non-small cell lung cancer via upregulating DR4/DR5 expression in a p53-dependent manner.芹菜素通过以p53依赖的方式上调DR4/DR5表达来增强非小细胞肺癌的TRAIL治疗效果。
Sci Rep. 2016 Oct 18;6:35468. doi: 10.1038/srep35468.